Patent ID: 6972294
Filing Date: 2005-12-06
Classification: C07C,C07D

Abstract:
1. A compound of formula (I) wherein A wherein heteroaryl is selected from the group consisting of furanyl, thionyl and pyridinyl; aryl is selected from the group consisting of phenyl and naphthyl; heteroaryloxy is a heteroaryl group linked to an oxygen atom, wherein said heteroaryl is selected from the group consisting of furanyl, thienyl and pyridinyl; heteroarylalkoxy is a heteroarylalkyl group linked to an oxygen atom, wherein said heteroarylalkyl is a straight or branched saturated carbon chain containing from 1 to 6 carbons substituted with a heteroaryl group, wherein said heteroaryl is selected from the group consisting of furanyl, thienyl and pyridinyl Z is C; Q is O or S; Ar is arylene or heteroarylene, wherein arylene is a divalent aromatic ring, selected from the group consisting of phenylene and naphthylene; heteroarylene is a divalent heteroaryl group selected from the group consisting of furanyl, thienyl and pyridinyl; R R M is OR R Y is oxygen; k is an integer from 1 to 2, n and m are 1; wherein heteroaryl is selected from the group consisting of furanyl, thienyl and pyridinyl; aryl is selected from the group consisting of phenyl and naphthyl; arylalkyl is selected from the group consisting of benzyl, phenethyl, 3-phenylpropyl, 1-naphtylmethyl and 2-(1-naphthyl)ethyl; heteroaryloxy is a heteroaryl group linked to an oxygen atom, wherein said heteroaryl is selected from the group consisting of furanyl, thienyl and pyridinyl; heteroarylalkoxy is a heteroarylalkyl group linked to an oxygen atom, wherein said heteroarylalkyl is a straight or branched saturated carbon chain containing from 1 to 6 carbons substituted with a heteroaryl group, wherein said heteroaryl is selected from the group consisting of furanyl, thiophenyl and pyridinyl; or a salt thereof with a pharmaceutically acceptable acid or base, or any optical isomer or mixture of optical isomers, or any tautomeric forms.